Veeva Systems and Zifo Join Forces to Revamp Quality Control in Biopharma
In a significant move for the biopharma sector, Veeva Systems (NYSE: VEEV) and Zifo today announced a strategic product partnership focused on modernizing quality control (QC) processes. Biopharma companies often face challenges with legacy systems that hinder efficiency and agility. The collaboration aims to address these issues by integrating Veeva LIMS with Zifo’s data integration and management platform, qcKen. This integration facilitates a seamless import of data from various source documents and existing LIMS directly into Veeva LIMS, essentially streamlining the configuration of laboratory master data during the implementation phase.
This technology not only reduces the complexity involved in setup but also lowers operational costs and accelerates the overall deployment process. According to Kannan Jagamoorthy, General Manager and Head of Zifo North America, this partnership is designed to empower customers to enhance their QC workflows and achieve faster operational turnarounds.
“By leveraging Veeva’s advanced capabilities, we are able to improve accuracy and efficiency in enforcing Good Manufacturing Practices (GMP), which is crucial for ensuring product quality,” he noted. The partnership is expected to allow biopharma companies to rapidly move past outdated QC systems, positioning them for a more innovative future.
Veeva LIMS was purpose-built specifically for life sciences organizations seeking to enhance their quality control operations, improve scalability, and expedite product release cycles. Ashley McMillan, Senior Director of Veeva LIMS Strategy, emphasized the importance of this partnership, explaining that it enables clients to implement Veeva LIMS more swiftly and derive greater value more quickly, which is vital in maintaining competitiveness in the fast-paced biopharma industry.
Zifo, recognized globally for its AI and data-driven solutions, serves a diverse clientele from the pharmaceutical and biotechnology sectors to food and beverage industries. Their extensive expertise complements Veeva’s reputation as a leader in cloud software for the life sciences sector. As more than 1,000 customers rely on Veeva's innovative solutions—from major biopharma companies to emerging biotech firms—the collaboration between Veeva and Zifo is set to uplift the standards of quality control processes across the industry.
The partnership builds on Zifo’s existing relationship as a Veeva Services Partner, reinforcing their commitment to offering integrated solutions that drive scientific innovations. Furthermore, by focusing on problems like test and specification data generation, and field deployment efficiency, the collaboration promises to streamline operations significantly and foster a faster return on investment for new Veeva LIMS customers.
This partnership highlights a strategic response to the industry's increasing demand for efficient, scalable, and reliable quality control systems. By bridging the capabilities of Veeva’s LIMS and Zifo's data management tools, both companies are poised to revolutionize how biopharmaceutical organizations manage quality control processes, navigating them towards a more efficient and compliant operational environment. With Veeva’s dedication to innovation and customer success and Zifo’s expertise in scientific data management, their collaborative effort is sure to create significant advancements in the realm of biopharmaceutical quality assurance and operational effectiveness.
As the life sciences continue to evolve, the need for adaptable and innovative QC solutions becomes indisputable, paving the way for enhanced efficiency, reduced cost, and improved product integrity in the biopharma landscape.
This partnership marks a pivotal moment, reshaping the future of quality control operations in the biopharmaceutical field and setting a new benchmark for excellence in product quality management.
This technology not only reduces the complexity involved in setup but also lowers operational costs and accelerates the overall deployment process. According to Kannan Jagamoorthy, General Manager and Head of Zifo North America, this partnership is designed to empower customers to enhance their QC workflows and achieve faster operational turnarounds.
“By leveraging Veeva’s advanced capabilities, we are able to improve accuracy and efficiency in enforcing Good Manufacturing Practices (GMP), which is crucial for ensuring product quality,” he noted. The partnership is expected to allow biopharma companies to rapidly move past outdated QC systems, positioning them for a more innovative future.
Veeva LIMS was purpose-built specifically for life sciences organizations seeking to enhance their quality control operations, improve scalability, and expedite product release cycles. Ashley McMillan, Senior Director of Veeva LIMS Strategy, emphasized the importance of this partnership, explaining that it enables clients to implement Veeva LIMS more swiftly and derive greater value more quickly, which is vital in maintaining competitiveness in the fast-paced biopharma industry.
Zifo, recognized globally for its AI and data-driven solutions, serves a diverse clientele from the pharmaceutical and biotechnology sectors to food and beverage industries. Their extensive expertise complements Veeva’s reputation as a leader in cloud software for the life sciences sector. As more than 1,000 customers rely on Veeva's innovative solutions—from major biopharma companies to emerging biotech firms—the collaboration between Veeva and Zifo is set to uplift the standards of quality control processes across the industry.
The partnership builds on Zifo’s existing relationship as a Veeva Services Partner, reinforcing their commitment to offering integrated solutions that drive scientific innovations. Furthermore, by focusing on problems like test and specification data generation, and field deployment efficiency, the collaboration promises to streamline operations significantly and foster a faster return on investment for new Veeva LIMS customers.
This partnership highlights a strategic response to the industry's increasing demand for efficient, scalable, and reliable quality control systems. By bridging the capabilities of Veeva’s LIMS and Zifo's data management tools, both companies are poised to revolutionize how biopharmaceutical organizations manage quality control processes, navigating them towards a more efficient and compliant operational environment. With Veeva’s dedication to innovation and customer success and Zifo’s expertise in scientific data management, their collaborative effort is sure to create significant advancements in the realm of biopharmaceutical quality assurance and operational effectiveness.
As the life sciences continue to evolve, the need for adaptable and innovative QC solutions becomes indisputable, paving the way for enhanced efficiency, reduced cost, and improved product integrity in the biopharma landscape.
This partnership marks a pivotal moment, reshaping the future of quality control operations in the biopharmaceutical field and setting a new benchmark for excellence in product quality management.
Topics Consumer Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.